I like the idea of maybe starting a generic application process before it expires.
The overarching question we have to ask is: Does the FDA care about drug prices?
Maybe we should expedite things when there's only one person making something and the price goes up at an alarming pace.
It's kind of hard to get bureaucrats out of Washington.
They just don't understand why it costs 500 percent more, particularly when the ingredients are quite inexpensive.
When I first heard about the EpiPen price increases going up 500 percent, I was like anybody else, outraged.
I'm of the belief that we need more oversight of the FDA.
We ought to think about how long patents should be.
I'm for patents. That's intellectual property.
We've been fighting for regulatory relief for these small community banks, and these credit unions, that, frankly, repre...
But I have to think about those 600 Kentuckians.
I share in my colleagues' outrage over the unethical and illegal sales practices at Wells Fargo...
So you've said that you want to make this right, but I would say that my constituents, who have been damaged by your con...
I think about the community banks and credit unions in my district.
I want to commend my colleague, Congressman Ellison, for looking at the issue of credit invisibility and looking at the ...
We feel that we are in an ideal position, being in that $6.5 billion size, that we understand the needs of the community...
Tough question. Obviously, the broad-brush stroke that most regulatory agencies take becomes a very, very difficult part...
As you can imagine, the number of prepaid cards that are out in the marketplace right now creates a huge regulatory burd...
